Cigna Corp (CI)
262.84
-1.73 (-0.65%)
NYSE · Last Trade: Mar 22nd, 10:33 AM EDT

Organon & Co. develops branded and biosimilar therapies with a focus on women’s health and specialty pharmaceuticals.
Via The Motley Fool · March 20, 2026

This clinical-stage biotech develops precision therapies for genetically defined diseases, targeting rare cancers and systemic mastocytosis.
Via The Motley Fool · March 20, 2026

This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance mechanisms.
Via The Motley Fool · March 20, 2026

HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.
Via The Motley Fool · March 15, 2026
The healthcare investment landscape was irrevocably altered this quarter as UnitedHealth Group (NYSE:UNH) witnessed a historic 20% collapse in its market valuation. The blue-chip titan, long considered the bedrock of the Dow Jones Industrial Average, shocked investors by forecasting its first annual revenue contraction in over 36 years. This
Via MarketMinute · March 11, 2026
Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.
Via Barchart.com · March 9, 2026
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the health insurance providers industry, i...
Via StockStory · March 8, 2026
Via Benzinga · March 6, 2026
What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...
Via StockStory · March 6, 2026
Cigna announced earlier on Tuesday that David M. Cordani will retire as CEO effective July 1, 2026, to be succeeded by Brian Evanko.
Via Stocktwits · March 3, 2026
The Cigna Group (NYSE:CI) shares are trading lower Tuesday after the company announced that David Cordani will retire as CEO.
Via Benzinga · March 3, 2026
Elevance Health has lagged behind the broader Dow Jones Industrial Average over the past year, and analysts are cautiously bullish about its future prospects.
Via Barchart.com · March 2, 2026
Over the last six months, Abbott Laboratories’s shares have sunk to $116.31, producing a disappointing 11.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Via StockStory · March 1, 2026
Cigna Group shows mixed price performance, yet sound fundamentals support analyst conviction for continued growth.
Via Barchart.com · February 27, 2026

Pacira (PCRX) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 26, 2026
Via Benzinga · February 26, 2026
Over the past six months, Molina Healthcare’s shares (currently trading at $145.75) have posted a disappointing 16.6% loss, well below the S&P 500’s 6.5% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Via StockStory · February 25, 2026
The "golden era" of the managed care sector came to an abrupt and painful halt this year, as UnitedHealth Group (NYSE: UNH) reported a staggering 16% decline in full-year 2025 net profits. This downturn, revealed in late January 2026, was driven by a "perfect storm" of rising medical utilization and
Via MarketMinute · February 25, 2026
Health insurance company Clover Health (NASDAQ:CLOV) will be reporting results tomorrow after market hours. Here’s what to look for.
Via StockStory · February 25, 2026
Health insurance company Alignment Healthcare (NASDAQ:ALHC)
will be reporting results this Thursday after market hours. Here’s what investors should know.
Via StockStory · February 24, 2026
Fertility benefits company Progyny (NASDAQ:PGNY)
will be reporting earnings this Thursday after market close. Here’s what to look for.
Via StockStory · February 24, 2026
As of late February 2026, the U.S. stock market has reached a definitive turning point that many analysts have predicted for years: the era of "narrow leadership" is officially ending. While the S&P 500 recently crossed the historic 7,000-point threshold, the real story isn't the headline number,
Via MarketMinute · February 24, 2026
As of February 20, 2026, UnitedHealth Group (NYSE: UNH) finds itself at a historic crossroads. For decades, the Minnetonka-based behemoth was the undisputed gold standard of the healthcare sector—a diversified "compounder" that consistently outpaced the S&P 500 while revolutionizing the way medical care is financed and delivered. However, the dawn of 2026 has brought unprecedented [...]
Via Finterra · February 20, 2026
As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector SPDR Fund (NYSE Arca: XLV) posted a robust 1.1% advance this week, standing in stark contrast
Via MarketMinute · February 18, 2026
Via Benzinga · February 17, 2026